Literature DB >> 15817659

Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

J M van Woerkom1, A A Kruize, M J G Wenting-van Wijk, E Knol, I C Bihari, J W G Jacobs, J W J Bijlsma, F P J G Lafeber, J A G van Roon.   

Abstract

OBJECTIVES: To investigate whether differences in T helper (Th) 1 and Th2 cell activity in salivary glands ("local") or ("peripheral") blood can discriminate between Sjögren's syndrome (SS) and non-Sjögren's sicca syndrome (nSS-sicca). Additionally, to study relationships of local and peripheral Th cell activities with each other and with disease activity measures.
METHODS: 62 sicca patients (32 with SS, 30 with nSS-sicca) were studied. Local Th1 (interferon gamma (IFNgamma)) and Th2 (interleukin (IL) 4) activity were determined using immunohistochemistry. T cell production of IFNgamma and IL4 in peripheral blood (PB) was determined by ELISA. Erythrocyte sedimentation rate (ESR) and serum IgG were considered disease activity measures.
RESULTS: ESR and serum IgG were higher in patients with SS than in patients with nSS-sicca. Local Th1 cell activity was higher and PB Th1 activity lower in patients with SS than in those with nSS-sicca. Th2 cell activity did not differ significantly between the patient groups. The ratio IFNgamma/IL4 was higher in salivary glands and lower in PB in patients with SS than in patients with nSS-sicca. Local and peripheral Th1 and Th2 cell activities correlated with ESR and serum IgG levels. ESR, serum IgG, and local or peripheral Th1 or Th2 cell activity did not discriminate between patients with SS and nSS-sicca.
CONCLUSIONS: An imbalance between Th1 and Th2 activity in sicca patients is clearly related to the severity of disease, but cannot be used to distinguish between patients with SS and those with nSS-sicca.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817659      PMCID: PMC1755251          DOI: 10.1136/ard.2004.031781

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjögren's syndrome.

Authors:  K Kohriyama; Y Katayama
Journal:  Autoimmunity       Date:  2000       Impact factor: 2.815

2.  The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.

Authors:  D I Mitsias; A G Tzioufas; C Veiopoulou; E Zintzaras; I K Tassios; O Kogopoulou; H M Moutsopoulos; G Thyphronitis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 3.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

4.  Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study.

Authors:  T Thepen; E G Langeveld-Wildschut; I C Bihari; D F van Wichen; F C van Reijsen; G C Mudde; C A Bruijnzeel-Koomen
Journal:  J Allergy Clin Immunol       Date:  1996-03       Impact factor: 10.793

5.  Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis.

Authors:  C M Verhoef; J A Van Roon; M E Vianen; C A Glaudemans; F P Lafeber; J W Bijlsma
Journal:  Scand J Immunol       Date:  1999-10       Impact factor: 3.487

6.  Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

Authors:  Y Ohyama; S Nakamura; G Matsuzaki; M Shinohara; A Hiroki; T Fujimura; A Yamada; K Itoh; K Nomoto
Journal:  Arthritis Rheum       Date:  1996-08

7.  Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.

Authors:  R I Fox; H I Kang; D Ando; J Abrams; E Pisa
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

8.  Long-term followup of patients with Sjögren's syndrome.

Authors:  A A Kruize; R J Hené; A van der Heide; C Bodeutsch; P C de Wilde; O P van Bijsterveld; J de Jong; T E Feltkamp; L Kater; J W Bijlsma
Journal:  Arthritis Rheum       Date:  1996-02

Review 9.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

10.  T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.

Authors:  F N Skopouli; P C Fox; V Galanopoulou; J C Atkinson; E S Jaffe; H M Moutsopoulos
Journal:  J Rheumatol       Date:  1991-02       Impact factor: 4.666

View more
  27 in total

Review 1.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

2.  Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.

Authors:  J M van Woerkom; A A Kruize; R Geenen; E N van Roon; R Goldschmeding; S M M Verstappen; J A G van Roon; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 3.  T helper cytokines in dry eye disease.

Authors:  Stephen C Pflugfelder; Rosa M Corrales; Cintia S de Paiva
Journal:  Exp Eye Res       Date:  2013-09-04       Impact factor: 3.467

4.  Protective Effect of Zengye Decoction () on Submandibular Glands in Nonobese Diabetic Mice.

Authors:  Cheng-Yin Li; Su-Ling Wu; Li-Xia Sun; Ting-Ting Yan; Yue Wang
Journal:  Chin J Integr Med       Date:  2014-09-24       Impact factor: 1.978

Review 5.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

Review 6.  Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.

Authors:  Hawra Aljanobi; Amarpreet Sabharwal; Bralavan Krishnakumar; Jill M Kramer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-01-24

7.  Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis.

Authors:  Alexandria Voigt; Katherine Bohn; Sukesh Sukumaran; Carol M Stewart; Indraneel Bhattacharya; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2018-04-19       Impact factor: 3.969

Review 8.  Interleukin-7 induced immunopathology in arthritis.

Authors:  S A Y Hartgring; J W J Bijlsma; F P J G Lafeber; J A G van Roon
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 9.  Cytokines in Sjögren's syndrome.

Authors:  N Roescher; P P Tak; G G Illei
Journal:  Oral Dis       Date:  2009-06-10       Impact factor: 3.511

10.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.